HB 332 Illinois House · 96th Regular Session

PRESCRIPTION DRUG ETHICAL ACT

Summary
Creates the Prescription Drug Ethical Marketing Act. Requires every manufacturer and labeler that sells prescription drugs in the State to disclose to the Director of Public Health the value, nature, and purpose of any gift, fee, payment, subsidy, or other economic benefit provided in connection with detailing or promotional or other marketing activities by the company, directly or through its pharmaceutical marketers, to any physician, hospital, nursing home, pharmacist, health benefit plan administrator, or any other person in the State authorized to prescribe or dispense prescription drugs. Requires the Director to report to the Governor and the General Assembly on the disclosures. Provides exceptions to the disclosures. Provides for injunctive relief and civil penalties for failure to disclose. Amends the State Finance Act to create the Prescription Drug Ethical Marketing Fund.
Bill status failed 1 of 4 stages cleared
Introduction
Jan 2009
Committee Review
Floor Vote
Governor
Introduced Jan 23, 2009 Last action Jan 11, 2011
Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
11
Key actions
0
Committee
5
Jan 11, 2011
House · Failed
Session Sine Die
Mar 15, 2010
House · Referred to committee
Rule 19(a) / Re-referred to Rules Committee
Jan 27, 2010
House · Referred to committee
Assigned to Human Services Committee
Mar 13, 2009
House · Referred to committee
Rule 19(a) / Re-referred to Rules Committee
Feb 4, 2009
House · Referred to committee
Assigned to Human Services Committee
Jan 27, 2009
House · Referred to committee
Referred to Rules Committee
0 primary · 1 co-sponsor

Sponsors

Role
Legislator
Party
State
District
Co
Photo of Jack D. Franks
Jack D. Franks
DDemocratic
IL
63